ANI Pharmaceuticals, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $67.1M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $5.7M | 8.6% |
| Business Acquisitions | $16.5M | 24.6% |
| Other Investing | $5.2M | 7.7% |
| Other Financing | $27.8M | 41.5% |
| Net Cash Flow | $11.9M | 17.7% |